Nociceptin/orphanin FQ modulation of rat midbrain dopamine neurons in primary culture

Neuroscience

Volumn 127, Issue 4, 2004, Pages 929-940

  Murphy, N P ^a,b   Tan, A M ^a   Lam, H A ^a   Maidment, N T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

aCSF; analysis of variance; ANOVA; AP 5; artificial cerebrospinal fluid; CompB; Compound B; D( ) 2 amino 5 phosphononpentanoic acid; DA; DAMGO; dopamine; GABA; glutamate; mesolimbic; opioid; orphanin FQ; ventral tegmental

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID; DOPAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NOCICEPTIN;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPOLARIZATION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; EVOKED CORTICAL RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOREGULATION; MESENCEPHALON; NERVE CELL; NERVE CELL CULTURE; NEUROMODULATION; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MESENCEPHALON; NEURONS; OPIOID PEPTIDES; RATS;

EID: 4143099271     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.05.055     Document Type: Article

References (40)

1. Buzas B., Rosenberger J., Cox B.M. Activity and cyclic AMP-dependent regulation of nociceptin/orphanin FQ gene expression in primary neuronal and astrocyte cultures. J Neurochem. 71:1998;556-563
2. Calo G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor A novel therapeutic target. Br J Pharmacol. 129:2000;1261-1283
3. Ciccocioppo R., Angeletti S., Sanna P.P., Weiss F., Massi M. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur J Pharmacol. 404:2000;153-159
4. Dalman F.C., O'Malley K.L. kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons. J Neurosci. 19:1999;5750-5757
5. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol. 375:1999;13-30
6. Di Giannuario A., Pieretti S., Catalani A., Loizzo A. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens A microdialysis study in rats. Neurosci Lett. 272:1999;183-186
7. Herz A. Opioid reward mechanisms A key role in drug abuse? Can J Physiol Pharmacol. 76:1998;252-258
8. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J Comp Neurol. 399:1998;139-151
9. Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behavior A unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev. 31:1999;6-41
10. Ikemoto S., Kohl R.R., McBride W.J. GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J Neurochem. 69:1997;137-143
11. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 12:1992;483-488
12. Konya H., Masuda H., Itoh K., Nagai K., Kakishita E., Matsuoka A. Modification of dopamine release by nociceptin in conscious rat striatum. Brain Res. 788:1998;341-344
13. Koob G.F., Le Moal M. Drug abuse Hedonic homeostatic dysregulation. Science. 278:1997;52-58
14. Kornblum H.I., Hurlbut D.E., Leslie F.M. Postnatal development of multiple opioid receptors in rat brain. Brain Res. 465:1987;21-41
15. Liu Z., Wang Y., Zhang J., Ding J., Guo L., Cui D., Fei J. Orphanin FQ An endogenous antagonist of rat brain dopamine transporter. Neuroreport. 12:2001;699-702
16. Lutfy K., Do T., Maidment N.T. Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berl). 154:2001;1-7
17. Maidment N.T., Chen Y., Tan A.M., Murphy N.P., Leslie F.M. Rat ventral midbrain dopamine neurons express the orphaninFQ/nociceptin receptor ORL-1. Neuroreport. 13:2002;1137-1140
18. Marti M., Guerrini R., Beani L., Bianchi C., Morari M. Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata A microdialysis study in the awake freely moving rat. Neuroscience. 112:2002;153-160
19. Meis S., Pape H.C. Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J Physiol. 532:2001;701-712
20. 3H]dopamine release from dissociated cell cultures of rat ventral mesencephalon. J Neurochem. 52:1989;1300-1310
21. Mount H., Quirion R., Chaudieu I., Boksa P. Stimulation of dopamine release from cultured rat mesencephalic cells by naturally occurring excitatory amino acids Involvement of both n-methyl-D-aspartate (NMDA) and non-NMDA receptor subtypes. J Neurochem. 55:1990;268-275
22. Murphy N.P., Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem. 73:1999;179-186
23. Murphy N.P., Ly H.T., Maidment N.T. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience. 75:1996;1-4
24. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832:1999;168-170
25. Neal C.R. Jr, Akil H., Watson S.J. Jr. Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J Chem Neuroanat. 22:2001;219-249
26. + evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol. 119:1996;1081-1083
27. Norton C.S., Neal C.R., Kumar S., Akil H., Watson S.J. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. J Comp Neurol. 444:2002;358-368
28. Ozaki S., Kawamoto H., Itoh Y., Miyaji M., Iwasawa Y., Ohta H. A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist J-113397. Eur J Pharmacol. 387:2000;R17-R18
29. Prasad B.M., Amara S.G. The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J Neurosci. 21:2001;7561-7567
30. Rayport S., Sulzer D., Shi W.X., Sawasdikosol S., Monaco J., Batson D., Rajendran G. Identified postnatal mesolimbic dopamine neurons in culture Morphology and electrophysiology. J Neurosci. 12:1992;4264-4280
31. Robinson T.E., Berridge K.C. The psychology and neurobiology of addiction An incentive-sensitization view. Addiction. 95:(Suppl 2):2000;S91-S117
32. Rohrbacher J., Sauer K., Lewen A., Misgeld U. Enhancement of synaptic excitation by GABAA receptor antagonists in rat embryonic midbrain culture. J Neurophysiol. 79:1998;1113-1116
33. Ronken E., Van Muiswinkel F.L., Mulder A.H., Schoffelmeer A.N. Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus. Eur J Pharmacol. 230:1993;349-355
34. Rouge-Pont F, Le Moal M, Piazza PV (2000) Functional GABA-dopamine interaction in primary culture of dopaminergic neurons. Soc Neurosci Abstr 535.517
35. Rouge-Pont F., Abrous D.N., Le Moal M., Piazza P.V. Release of endogenous dopamine in cultured mesencephalic neurons Influence of dopaminergic agonists and glucocorticoid antagonists. Eur J Neurosci. 11:1999;2343-2350
36. Seutin V., Franchimont N., Massotte L., Dresse A. Comparison of the effect of morphine on locus coeruleus noradrenergic and ventral tegmental area dopaminergic neurons in vitro. Life Sci. 46:1990;1879-1885
37. 3H]dopamine release from rat ventral mesencephalic dissociated cell cultures. Mol Pharmacol. 42:1992;575-583
38. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 51:1998;13-22
39. Zheng F., Grandy D.K., Johnson S.W. Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro. Br J Pharmacol. 136:2002;1065-1071
40. Zhu Y., Hsu M.S., Pintar J.E. Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci. 18:1998;2538-2549